Stocktoria
Cabaletta Bio, Inc. CABA
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2019-10-25
Cabaletta Bio, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 4,756,219 | $35.6M | 4.73% |
| CITADEL ADVISORS LLC | 4,132,812 | $12.9M | 4.11% |
| MILLENNIUM MANAGEMENT LLC | 2,068,491 | $6.4M | 2.06% |
| RENAISSANCE TECHNOLOGIES LLC | 1,535,300 | $4.8M | 1.53% |
| TWO SIGMA INVESTMENTS, LP | 1,410,931 | $4.4M | 1.4% |
| D. E. Shaw & Co., Inc. | 90,652 | $281,928 | 0.09% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.